Actuate Therapeutics (ACTU) PE Ratio: History & Chart

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T18:00:34.404Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:00:34.404Z.

Quote observation: 2026-10-06T17:58:48.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 0.8105
Unrounded diluted TTM EPS · period ending 2026-06-30: -0.89

FMP input reference: a29a88061d86e64317c53e71c63756e58f7ffa0b55551e6148327154cc786467

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

ACTU PE Ratio Metrics

PE RATIO

N/A

ACTU Competitors' PE Ratio

ACTU

Actuate Therapeutics Inc

Current

Market Cap

$19.39M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PIII

P3 Health Partners Inc.

vs ACTU

Market Cap

$19.30M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NXTC

NextCure, Inc.

vs ACTU

Market Cap

$20.32M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NEUP

Neuphoria Therapeutics Inc.

vs ACTU

Market Cap

$18.54M

PE Ratio

N/A

TTM Avg

2.38

3Y Avg

2.38

5Y Avg

2.38

QNTM

Quantum BioPharma Ltd.

vs ACTU

Market Cap

$21.40M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ESLA

Estrella Immunopharma, Inc.

vs ACTU

Market Cap

$17.71M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MODD

Modular Medical, Inc.

vs ACTU

Market Cap

$21.56M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COSM

Cosmos Health Inc.

vs ACTU

Market Cap

$17.50M

PE Ratio

N/A

TTM Avg

49.08

3Y Avg

49.08

5Y Avg

49.08

PAVM

PAVmed Inc.

vs ACTU

Market Cap

$17.27M

PE Ratio

N/A

TTM Avg

0.60

3Y Avg

0.60

5Y Avg

0.60

AYTU

Aytu BioPharma, Inc.

vs ACTU

Market Cap

$22.11M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Actuate Therapeutics Inc (ACTU)	$19.39M	N/A	N/A	N/A	N/A
P3 Health Partners Inc. (PIII)vs ›	$19.30M	N/A	N/A	N/A	N/A
NextCure, Inc. (NXTC)vs ›	$20.32M	N/A	N/A	N/A	N/A
Neuphoria Therapeutics Inc. (NEUP)vs ›	$18.54M	N/A	2.38	2.38	2.38
Quantum BioPharma Ltd. (QNTM)vs ›	$21.40M	N/A	N/A	N/A	N/A
Estrella Immunopharma, Inc. (ESLA)vs ›	$17.71M	N/A	N/A	N/A	N/A
Modular Medical, Inc. (MODD)vs ›	$21.56M	N/A	N/A	N/A	N/A
Cosmos Health Inc. (COSM)vs ›	$17.50M	N/A	49.08	49.08	49.08
PAVmed Inc. (PAVM)vs ›	$17.27M	N/A	0.60	0.60	0.60
Aytu BioPharma, Inc. (AYTU)vs ›	$22.11M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$0.81

÷

Forward EPS (Est.)

$-0.73

=

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

ACTU PE Ratio Metrics

ACTU Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics